Gilbert Lynn Marks insider trades
Open-market stock purchases and sales by Gilbert Lynn Marks, Unknown at AN2 Therapeutics, Inc, from SEC Form 4 filings since May 12, 2022.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Apr 10, 2026 | ANTX AN2 Therapeutics, Inc | Bought (not open market) | — |
| Mar 19, 2026 | ANTX AN2 Therapeutics, Inc | Bought (not open market) | $41.7K |
| Mar 19, 2026 | ANTX AN2 Therapeutics, Inc | Sold (not open market) | $70.3K |
| Mar 19, 2026 | ANTX AN2 Therapeutics, Inc | Bought (not open market) | $40.5K |
| Mar 19, 2026 | ANTX AN2 Therapeutics, Inc | Sold (not open market) | $179K |
| Mar 19, 2026 | ANTX AN2 Therapeutics, Inc | Bought (not open market) | $92.8K |
| Mar 19, 2026 | ANTX AN2 Therapeutics, Inc | Sold (not open market) | $140K |
| Feb 20, 2026 | ANTX AN2 Therapeutics, Inc | Bought (not open market) | — |
| Jan 12, 2026 | ANTX AN2 Therapeutics, Inc | Bought (not open market) | — |
| Oct 10, 2025 | ANTX AN2 Therapeutics, Inc | Bought (not open market) | — |
Companies traded
- ANTX AN2 Therapeutics, Inc: other filings, last Apr 10, 2026